SCHEMBL23528985

SCHEMBL23528985

CC(C)(C)OC(=O)N1CCC(=C(F)c2cccc(NC(=O)c3c(F)cc(F)cc3F)n2)CC1

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR1F P30939 12/20 0.72
HTR1A P08908 1/20 0.72
HTR1B P28222 1/20 0.72
HTR2A P28223 1/20 0.72
HTR2C P28335 1/20 0.72
HTR2B P41595 1/20 0.72
CHRM5 P08912 1/20 0.52
DRD5 P21918 1/20 0.52
HTR1D P28221 1/20 0.52
HTR1E P28566 1/20 0.52
HTR7 P34969 1/20 0.52
OPRK1 P41145 1/20 0.52
TMEM97 Q5BJF2 1/20 0.52
SIGMAR1 Q99720 1/20 0.52
MAP3K5 Q99683 4/20 0.43
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
GRM5 P41594 1/20 0.39
KIF18A Q8NI77 1/20 0.39
KDR P35968 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23528970 0.89 HTR1F (0.73) HTR1FHTR1AHTR1BHTR2AHTR2C
SCHEMBL23528998 0.87 HTR1F (0.71) HTR1FHTR1AHTR1BHTR2AHTR2C
SCHEMBL28807271 0.85 HTR1F (0.79) HTR1FHTR1AHTR1BHTR2AHTR2C
SCHEMBL23528979 0.85 HTR1F (0.72) HTR1FHTR1AHTR1BHTR2AHTR2C
SCHEMBL23528935 0.85 HTR1F (0.52) HTR1FHTR1AHTR1BHTR2AHTR2C
SCHEMBL29644497 0.84 HTR1F (1.00) HTR1FHTR1AHTR1BHTR2AHTR2C
SCHEMBL21770793 0.84 HTR1F (1.00) HTR1FHTR1AHTR1BHTR2AHTR2C
SCHEMBL23528957 0.84 HTR1F (0.74) HTR1FHTR1AHTR1BHTR2AHTR2C
SCHEMBL23529013 0.83 HTR1F (0.49) HTR1FHTR1AHTR1BHTR2AHTR2C
SCHEMBL23528991 0.83 HTR1F (0.71) HTR1FHTR1AHTR1BHTR2AHTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11858910-B2 Pyridinylmethylenepiperidine derivatives and uses thereof SUNSHINE LAKE PHARMA CO., LTD. (CN) 2024-01-02 US disclosed
US-20210188803-A1 PYRIDINYLMETHYLENEPIPERIDINE DERIVATIVES AND USES THEREOF SUNSHINE LAKE PHARMA CO., LTD. (CN) 2021-06-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11858910-B2 Pyridinylmethylenepiperidine derivatives and uses thereof HTR1F, HTR1A, HTR5A HTR1F 1/4885HTR1A 2/4885HTR1B 6/4885
US-20210188803-A1 PYRIDINYLMETHYLENEPIPERIDINE DERIVATIVES AND USES THEREOF HTR1F, HTR1A, HTR5A HTR1F 1/4885HTR1A 2/4885HTR1B 6/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.